https://www.openbell.ai/ 2026-10-09T13:42:02.877Z hourly 1.0 https://www.openbell.ai/support 2026-10-09T13:42:02.877Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-09T13:42:02.877Z monthly 0.5 https://www.openbell.ai/terms 2026-10-09T13:42:02.877Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-09T13:42:02.877Z hourly 0.8 https://www.openbell.ai/news/BA:1791553317513 2026-10-09T13:41:57.513Z daily 0.9 https://cdn.brandfetch.io/BA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On Boeing with Overweight Rating, Announces Price Target of $300 Barclays analyst Anthony Valentini has initiated coverage on Boeing (NYSE: BA) with an Overweight rating. The firm has set a price target of $300 for the stock. https://www.openbell.ai/news/ARM:1791553302638 2026-10-09T13:41:42.638Z daily 0.9 https://cdn.brandfetch.io/ARM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported On October 8th: &#39;Networking Startup Eliyan Draws Takeover Interest, Held Early Talks With Arm&#39;- The Information Networking startup Eliyan has attracted takeover interest and has held preliminary discussions with Arm regarding a potential acquisition. The talks indicate a strategic move within the networking industry, although specific financial details or terms of the discussions have not been disclosed. https://www.openbell.ai/news/SPCX:1791553179684 2026-10-09T13:39:39.684Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On SpaceX with Overweight Rating, Announces Price Target of $254 Barclays analyst Anthony Valentini has initiated coverage on SpaceX (NASDAQ: SPCX) with an Overweight rating. The firm has set a price target of $254 for the stock. https://www.openbell.ai/news/HUM:1791553059807 2026-10-09T13:37:39.807Z daily 0.9 https://cdn.brandfetch.io/HUM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Humana Stock Hits 52-Week High After Medicare Ratings Boost Humana Inc. announced that 95% of its Medicare Advantage members are enrolled in plans rated at least four stars by the Centers for Medicare and Medicaid Services for 2027, contributing to a 16.09% increase in its stock price to $449.41, marking a new 52-week high. The company secured six contracts with a 4.5-star distinction and 12 contracts with a 4.0-star rating, an increase of 11 contracts compared to the previous year. Humana reaffirmed its fiscal 2026 adjusted earnings guidance of at least $9 per share, aligning closely with the consensus estimate of $9.15. https://www.openbell.ai/news/SOBO:1791552838631 2026-10-09T13:33:58.631Z daily 0.9 https://cdn.brandfetch.io/SOBO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Downgrades South Bow to Underweight, Lowers Price Target to $33 Barclays analyst Theresa Chen has downgraded South Bow (NYSE: SOBO) from Equal-Weight to Underweight. The price target for the stock has been reduced from $35 to $33. https://www.openbell.ai/news/CNNE:1791552826310 2026-10-09T13:33:46.310Z daily 0.9 https://cdn.brandfetch.io/CNNE/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Cannae Holdings, Raises Price Target to $17 RBC Capital analyst Kenneth S. Lee has maintained an Outperform rating on Cannae Holdings (NYSE: CNNE) and raised the price target from $16 to $17. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/SOBO:1791552572771 2026-10-09T13:29:32.771Z daily 0.9 https://cdn.brandfetch.io/SOBO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Downgrades South Bow to Underweight, Lowers Price Target to C$47 Barclays analyst Theresa Chen has downgraded South Bow (TSX: SOBO) from Equal-Weight to Underweight. The price target for the stock has been reduced from C$49 to C$47. https://www.openbell.ai/news/EIF:1791552489157 2026-10-09T13:28:09.157Z daily 0.9 https://cdn.brandfetch.io/EIF/w/400/h/400?c=1idopYfmtR7ZKg8QMud RBC Capital Maintains Outperform on Exchange Income, Raises Price Target to C$158 RBC Capital analyst James McGarragle has maintained an Outperform rating on Exchange Income (TSX: EIF) and raised the price target from C$156 to C$158. This revision reflects a positive outlook for the company's performance. https://www.openbell.ai/news/RTX:1791552370742 2026-10-09T13:26:10.742Z daily 0.9 https://cdn.brandfetch.io/RTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On RTX with Overweight Rating, Announces Price Target of $223 Barclays analyst Anthony Valentini has initiated coverage on RTX (NYSE: RTX) with an Overweight rating. The firm has set a price target of $223 for the stock. https://www.openbell.ai/news/SPCX:1791552351594 2026-10-09T13:25:51.594Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud TD Cowen Reiterates Buy on SpaceX, Maintains $200 Price Target TD Cowen analyst Gregory Williams has reiterated a 'Buy' rating on SpaceX (NASDAQ: SPCX) and maintained a price target of $200 for the stock. This endorsement reflects confidence in SpaceX's performance and potential in the market. https://www.openbell.ai/news/TORO:1791552077959 2026-10-09T13:21:17.959Z daily 0.9 https://cdn.brandfetch.io/TORO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Toro Q2 EPS $(0.13) Down From $0.02 YoY, Sales $6.950M Up From $4.058M YoY Toro (NASDAQ: TORO) reported a Q2 loss of $(0.13) per share, a significant decline from earnings of $0.02 per share in the same quarter last year, marking a 750% decrease. However, the company's sales increased to $6.950 million, reflecting a 71.26% growth from $4.058 million in the previous year. https://www.openbell.ai/news/ABBV:1791552067279 2026-10-09T13:21:07.279Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Reiterates Buy on AbbVie, Maintains $288 Price Target Guggenheim analyst Vamil Divan has reiterated a Buy rating on AbbVie (NYSE: ABBV) and has maintained a price target of $288 for the stock. This endorsement reflects confidence in AbbVie's performance and potential in the market. https://www.openbell.ai/news/RKLB:1791552039862 2026-10-09T13:20:39.862Z daily 0.9 https://cdn.brandfetch.io/RKLB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On Rocket Lab with Overweight Rating, Announces Price Target of $85 Barclays analyst Anthony Valentini has initiated coverage on Rocket Lab (NASDAQ: RKLB) with an Overweight rating. The firm has set a price target of $85 for the stock. https://www.openbell.ai/news/VIVK:1791551962613 2026-10-09T13:19:22.613Z daily 0.9 https://cdn.brandfetch.io/VIVK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vivakor Agrees To Acquire Direct Midstream For $40M Vivakor, Inc. (NASDAQ: VIVK) has announced a non-binding Letter of Intent to acquire Direct Midstream, LLC for $40 million. Direct Midstream is a water midstream company based in Midland, Texas, specializing in produced water infrastructure and oilfield waste management services in the Permian Basin. This acquisition aims to enhance Vivakor's integrated energy services portfolio. https://www.openbell.ai/news/VIVK:1791551905095 2026-10-09T13:18:25.095Z daily 0.9 https://cdn.brandfetch.io/VIVK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vivakor shares are trading higher after the company announced it will acquire Direct Midstream. openbell Financial News https://www.openbell.ai/news/VIVK:1791551895517 2026-10-09T13:18:15.517Z daily 0.9 https://cdn.brandfetch.io/VIVK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vivakor shares are trading higher after the company announced it will acquire Direct Midstream. openbell Financial News https://www.openbell.ai/news/SPCB:1791551807806 2026-10-09T13:16:47.806Z daily 0.9 https://cdn.brandfetch.io/SPCB/w/400/h/400?c=1idopYfmtR7ZKg8QMud SuperCom Receives Two New County-Level Electronic Monitoring Contracts With Adult, Juvenile Probation Agencies In Texa s SuperCom (NASDAQ: SPCB) has secured two new county-level electronic monitoring contracts with adult and juvenile probation agencies in Texas, marking its fourth and fifth contracts since expanding in the state in December 2025. These contracts will replace the county's existing electronic monitoring providers. https://www.openbell.ai/news/PLTR:1791551781484 2026-10-09T13:16:21.484Z daily 0.9 https://cdn.brandfetch.io/PLTR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On Palantir Technologies with Overweight Rating, Announces Price Target of $265 Barclays analyst Anthony Valentini has initiated coverage on Palantir Technologies (NASDAQ: PLTR) with an Overweight rating. The firm has set a price target of $265 for the stock. https://www.openbell.ai/news/SKIN:1791551771490 2026-10-09T13:16:11.490Z daily 0.9 https://cdn.brandfetch.io/SKIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud SkinHealth Systems Announces 1-For-20 Reverse Stock Split, Effective October 14 openbell Financial News https://www.openbell.ai/news/DCO:1791551751972 2026-10-09T13:15:51.972Z daily 0.9 https://cdn.brandfetch.io/DCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Guggenheim Initiates Coverage On Ducommun with Buy Rating, Announces Price Target of $246 Guggenheim analyst Michael Ciarmoli has initiated coverage on Ducommun (NYSE: DCO) with a Buy rating. The firm has set a price target of $246 for the company's stock. https://www.openbell.ai/news/NOC:1791551730584 2026-10-09T13:15:30.584Z daily 0.9 https://cdn.brandfetch.io/NOC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On Northrop Grumman with Underweight Rating, Announces Price Target of $419 Barclays analyst Anthony Valentini has initiated coverage on Northrop Grumman (NYSE: NOC) with an Underweight rating. The firm has set a price target of $419 for the stock. https://www.openbell.ai/news/LITE:1791551528101 2026-10-09T13:12:08.101Z daily 0.9 https://cdn.brandfetch.io/LITE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Lumentum Holdings shares are trading higher following a report suggesting the company sold out of AI server parts until 2029. openbell Financial News https://www.openbell.ai/news/CRWD:1791551504488 2026-10-09T13:11:44.488Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/09/CrowdStrike.jpg?width=250&height=187 CrowdStrike To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday Needham has raised the price target for CrowdStrike Holdings Inc (NASDAQ: CRWD) from $250 to $310, maintaining a Buy rating. CrowdStrike shares closed at $263.01 on Thursday. This adjustment reflects a positive outlook from analysts, suggesting potential growth for the stock. https://www.openbell.ai/news/KRMN:1791551382132 2026-10-09T13:09:42.132Z daily 0.9 https://cdn.brandfetch.io/KRMN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On Karman Holdings with Overweight Rating, Announces Price Target of $79 Barclays analyst Anthony Valentini has initiated coverage on Karman Holdings (NYSE: KRMN) with an Overweight rating. The firm has set a price target of $79 for the stock. https://www.openbell.ai/news/BMRN:1791551372508 2026-10-09T13:09:32.508Z daily 0.9 https://cdn.brandfetch.io/BMRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud BioMarin Pharmaceutical To Present New Data From Studies Of VOXZOGO In Children With Achondroplasia And Hypochondroplasia And From Studies Of Investigational Long-Acting BMN 333 At American Society For Bone And Mineral Research Meeting; New Analysis Showcases Impact Of VOXZOGO In Foramen Magnum And Craniocervical Junction Growth BioMarin Pharmaceutical is set to present new data on VOXZOGO, a treatment for achondroplasia and hypochondroplasia, at the American Society for Bone and Mineral Research meeting. The company has submitted a supplemental New Drug Application to the FDA for VOXZOGO, which could become the first targeted therapy for hypochondroplasia with a potential launch in 2027. The presentations will include findings from various studies, including the impact of VOXZOGO on bone growth and results from the Phase 3 ENERGY 3 trial of BMN 401. https://www.openbell.ai/news/VIVK:1791551311885 2026-10-09T13:08:31.885Z daily 0.9 https://cdn.brandfetch.io/VIVK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vivakor shares are trading higher after the company announced it will acquire Direct Midstream. openbell Financial News https://www.openbell.ai/news/JOBY:1791551286566 2026-10-09T13:08:06.566Z daily 0.9 https://cdn.brandfetch.io/JOBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Downgrades Joby Aviation to Underweight, Lowers Price Target to $4 Barclays analyst Anthony Valentini has downgraded Joby Aviation (NYSE: JOBY) from Equal-Weight to Underweight. The price target for the stock has been reduced from $6 to $4. https://www.openbell.ai/news/VEEA:1791551172090 2026-10-09T13:06:12.090Z daily 0.9 https://cdn.brandfetch.io/VEEA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Veea shares are trading higher after the company announced it regained Nasdaq compliance. openbell Financial News https://www.openbell.ai/news/EDBL:1791551170558 2026-10-09T13:06:10.558Z daily 0.9 https://cdn.brandfetch.io/EDBL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Edible Garden Receives Preliminary Approval From The NJ Economic Development Authority To Sell Its Tax Credits For FY26 Edible Garden has received preliminary approval from the New Jersey Economic Development Authority (NJEDA) to sell its tax credits for fiscal year 2026, potentially providing a source of non-dilutive capital to support its operations and growth objectives. The company aims to enhance its efficiency and scalability through its proprietary GreenThumb 2.0 technology and expand its product portfolio, particularly in the ready-to-drink beverage category. Participation in the NJEDA program is contingent upon final allocation, identification of an approved corporate buyer, and completion of necessary transactions. https://www.openbell.ai/news/ZETA:1791551147867 2026-10-09T13:05:47.867Z daily 0.9 https://cdn.brandfetch.io/ZETA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Keybanc Maintains Overweight on Zeta Global Holdings, Raises Price Target to $38 Keybanc analyst Jack Nichols has maintained an Overweight rating on Zeta Global Holdings (NYSE: ZETA) and raised the price target from $27 to $38. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/MUX:1791551144408 2026-10-09T13:05:44.408Z daily 0.9 https://cdn.brandfetch.io/MUX/w/400/h/400?c=1idopYfmtR7ZKg8QMud McEwen Agrees To Sell Fuller, Paymaster To Dome Mine For $55M McEwen Inc. has agreed to sell its Fuller and Paymaster properties to Dome Mine Ltd. for a total of US$55 million. This transaction will allow McEwen to monetize non-core assets and provide additional capital for investment in its operations and development projects. The company aims to produce 250,000–300,000 gold equivalent ounces annually by 2030 with minimal to no share dilution. https://www.openbell.ai/news/ODTX:1791551138614 2026-10-09T13:05:38.614Z daily 0.9 https://cdn.brandfetch.io/ODTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Odyssey Therapeutics shares are trading higher after Raymond James initiated coverage on the stock with an Outperform rating and announced a $42 price target. openbell Financial News https://www.openbell.ai/news/DPC:1791551064244 2026-10-09T13:04:24.244Z daily 0.9 https://cdn.brandfetch.io/DPC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On DPC Holdings with Overweight Rating, Announces Price Target of $49 Barclays analyst Anthony Valentini has initiated coverage on DPC Holdings (NYSE: DPC) with an Overweight rating. The firm has set a price target of $49 for the stock. https://www.openbell.ai/news/KOPN:1791551057460 2026-10-09T13:04:17.460Z daily 0.9 https://cdn.brandfetch.io/KOPN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kopin shares are trading higher after the company announced it secured an additional U.S. Army IBAS Award for color MicroLED technology. openbell Financial News https://www.openbell.ai/news/MLYS:1791551048232 2026-10-09T13:04:08.232Z daily 0.9 https://cdn.brandfetch.io/MLYS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Mineralys Therapeutics Reports New Data Of Analysis From Its Pivotal Phase 3 Launch-HTN Study Mineralys Therapeutics, Inc. (Nasdaq: MLYS) announced new data from its pivotal Phase 3 Launch-HTN trial, revealing that 46% of participants treated with lorundrostat achieved the recommended office systolic blood pressure target of <130 mmHg by Week 12. These findings were presented at the American Heart Association Hypertension Scientific Sessions 2026, held from October 7-11 in Arlington, VA. https://www.openbell.ai/news/RBNE:1791551027418 2026-10-09T13:03:47.418Z daily 0.9 https://cdn.brandfetch.io/RBNE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Robin Energy Announces Purchase Of 90,000 Volare Shipping Shares At NOK 154.00/Share In Private Placement openbell Financial News https://www.openbell.ai/news/IONQ:1791550993534 2026-10-09T13:03:13.534Z daily 0.9 https://cdn.brandfetch.io/IONQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud IonQ Says Quantum Networking Link Achieved More Than 1,000 Entanglements Per Second, More Than 4x Prior Record openbell Financial News https://www.openbell.ai/news/MCHP:1791550973546 2026-10-09T13:02:53.546Z daily 0.9 https://cdn.brandfetch.io/MCHP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Microchip Technology Acquires VORAGO Technologies; Financial Terms Not Disclosed Microchip Technology Incorporated (Nasdaq: MCHP) has acquired VORAGO Technologies, a provider of radiation-hardened and radiation-tolerant microcontrollers and microprocessors. The financial terms of the acquisition were not disclosed, and it is not expected to have a material impact on Microchip's consolidated financial results. https://www.openbell.ai/news/CAE:1791550963872 2026-10-09T13:02:43.872Z daily 0.9 https://cdn.brandfetch.io/CAE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On CAE with Overweight Rating, Announces Price Target of C$54 Barclays analyst Anthony Valentini has initiated coverage on CAE with an Overweight rating and set a price target of C$54. This marks a positive outlook for the company in the market. https://www.openbell.ai/news/ACHR:1791550960918 2026-10-09T13:02:40.918Z daily 0.9 https://cdn.brandfetch.io/ACHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Archer Aviation shares are trading higher after Barclays upgraded the stock from Equal-Weight to Overweight and raised its price target from $4.5 to $8. openbell Financial News https://www.openbell.ai/news/VIVK:1791550936709 2026-10-09T13:02:16.709Z daily 0.9 https://cdn.brandfetch.io/VIVK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vivakor Agrees To Acquire Direct Midstream For $40M Vivakor, Inc. (NASDAQ: VIVK) has announced a non-binding Letter of Intent to acquire Direct Midstream, LLC for $40 million. Direct Midstream is a water midstream company based in Midland, Texas, specializing in produced water infrastructure and oilfield waste management services in the Permian Basin. This acquisition aims to enhance Vivakor's integrated energy services. https://www.openbell.ai/news/CAE:1791550894175 2026-10-09T13:01:34.175Z daily 0.9 https://cdn.brandfetch.io/CAE/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On CAE with Overweight Rating, Announces Price Target of $38 Barclays analyst Anthony Valentini has initiated coverage on CAE (NASDAQ: CAE) with an Overweight rating. The firm has set a price target of $38 for the stock. https://www.openbell.ai/news/BETA:1791550788698 2026-10-09T12:59:48.698Z daily 0.9 https://cdn.brandfetch.io/BETA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Initiates Coverage On BETA Technologies with Overweight Rating, Announces Price Target of $35 Barclays analyst Anthony Valentini has initiated coverage on BETA Technologies (NYSE: BETA) with an Overweight rating. The firm has set a price target of $35 for the stock. https://www.openbell.ai/news/AMZN:1791550617940 2026-10-09T12:56:57.940Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/09/Los-Angeles-California---February-14-202.jpg?width=250&height=187 Amazon Is Undervalued, Says Analyst — and AI Could Be Its Biggest Advantage Amazon.com Inc. (NASDAQ: AMZN) stock rose nearly 1% in premarket trading, reflecting improved market sentiment. Analyst Laura Martin from Needham considers Amazon's stock undervalued, highlighting its strong customer ecosystem and growing AI adoption, with 67% of users utilizing AI for product searches. Amazon's cloud business is growing at 40% with margins around 35%, contrasting sharply with its lower-margin e-commerce operations. The stock has a consensus Buy rating and an average price forecast of $335, with recent analyst price targets ranging from $250 to $400. https://www.openbell.ai/news/ACHR:1791550598050 2026-10-09T12:56:38.050Z daily 0.9 https://cdn.brandfetch.io/ACHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Barclays Upgrades Archer Aviation to Overweight, Raises Price Target to $8 Barclays analyst Anthony Valentini has upgraded Archer Aviation (NYSE: ACHR) from Equal-Weight to Overweight. The price target for the stock has been raised from $4.5 to $8. https://www.openbell.ai/news/SPCX:1791550590555 2026-10-09T12:56:30.555Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/09/Starlink-is-a-satellite-internet-constel.jpg?width=250&height=187 Elon Musk Says SpaceX Can Outgrow Earth. The First Victim May Be Your Phone Bill SpaceX (NASDAQ: SPCX) is pursuing a significant growth opportunity in the mobile network sector with its Starlink service, aiming to compete with major carriers like Verizon, AT&T, and T-Mobile. The company has agreed to acquire Grain Management's low-band wireless spectrum licenses, which will enhance its mobile connectivity capabilities alongside its planned deployment of 15,000 next-generation Starlink satellites. This strategic move could challenge traditional telecom providers by potentially offering competitive pricing and reliable service, although it still requires regulatory approval and successful implementation. https://www.openbell.ai/news/SECZ:1791550562838 2026-10-09T12:56:02.838Z daily 0.9 https://cdn.brandfetch.io/SECZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citizens Maintains Market Outperform on Securitize Holdings, Raises Price Target to $17 Citizens analyst Devin Ryan has reaffirmed a Market Outperform rating on Securitize Holdings (NYSE: SECZ) and increased the price target from $15 to $17. https://www.openbell.ai/news/LITE:1791550486355 2026-10-09T12:54:46.355Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/09/Konskie--Poland---March-11--2025-Lumentu.jpg?width=250&height=187 Lumentum Stock Rises After CEO Says AI Demand Has the Company Sold Out Through Early 2029 Lumentum Holdings Inc. (NASDAQ: LITE) shares rose 6.05% to $1,112.03 after CEO Michael Hurlston announced that the company's optoelectronic components are sold out through early 2029 due to strong demand from AI data centers. Hurlston stated that Lumentum is unable to meet approximately 70% of demand for some products through next year and 30% for others through 2028. The company is expanding its production capacity with a new facility in North Carolina and an expansion in Japan, but relief from the capacity shortfall is not expected until 2029 or 2030. Additionally, Lumentum benefits from a $2 billion investment from NVIDIA, and Stifel Nicolaus has raised its price target on the stock to $1,232. https://www.openbell.ai/news/ZS:1791550471368 2026-10-09T12:54:31.368Z daily 0.9 https://cdn.brandfetch.io/ZS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citizens Maintains Market Outperform on Zscaler, Raises Price Target to $265 Citizens analyst Rustam Kanga has reaffirmed a Market Outperform rating on Zscaler (NASDAQ: ZS) and increased the price target from $210 to $265. This adjustment reflects a positive outlook on the company's performance in the market. https://www.openbell.ai/news/ALHC:1791550150913 2026-10-09T12:49:10.913Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/09/Medicare-Advantage-Type-Of-Health-Insura.jpg?width=250&height=187 Alignment Healthcare Stock Hit by Bearish Outlook After Costly Medicare Advantage Rating Downgrade Alignment Healthcare Inc. (NASDAQ: ALHC) is facing stock pressure after its California H3815 HMO contract received a downgrade to a 3.5-star rating for 2027, down from 4.0 stars in 2026. This contract represents over 75% of the company's total health plan members and is crucial for qualifying for bonus payments. Following the news, Alignment's shares dropped 22.73% to $6.73, marking a new 52-week low. Despite six of its seven Medicare Advantage contracts earning 4 stars or higher, the downgrade could significantly impact the company's financial outlook.